Real-World Management of Thyroid Cancer with TRK Inhibitors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.

September 7, 2018

Healthcare Team’s Relationship to the Patient

Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient.

July 13, 2021

NTRK Gene Fusion Enrichment in Patient Subpopulations

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, identify specific subpopulations of patients in which NTRK gene fusions may be commonly uncovered.